Federica Riccardo

15PUBLICATIONS
44CO-AUTHORS
Solid tumoursMolecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 16, 2026
The Osteosarcoma Tumor Microenvironment: Supportive of Tumor Progression, Hostile to Immunity, but Therapeutically Targetable.

|Dec 11, 2025
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer.

Lidia Tarone, Antonella Iacoviello, Antonino Di Lorenzo

|Mar 10, 2025
Clinical evaluation of HuDo-CSPG4 DNA electroporation as adjuvant treatment for canine oral malignant melanoma: comparison of two vaccination protocols.

Mariateresa Camerino, Davide Giacobino, Lidia Tarone

|Dec 23, 2022
Improving Osteosarcoma Treatment: Comparative Oncology in Action.

Lidia Tarone, Katia Mareschi, Elisa Tirtei

|Aug 26, 2022
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.

Junbiao Wang, Alessia Lamolinara, Laura Conti

|Jun 27, 2022
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.

Antonino Di Lorenzo, Elisabetta Bolli, Roberto Ruiu

Pageof 3

Frequent Collaborators

13 joint publications

Federica Cavallo

8 joint publications

Federica Cavallo

8 joint publications

Laura Conti

5 joint publications

Giuseppina Barutello